G1 Therapeutics, Inc. (GTHX) Financials
GTHX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 121.5 million | 86.2 million |
2023-09-30 | 133.1 million | 90.1 million |
2023-06-30 | 147.9 million | 90.3 million |
2023-03-31 | 162.0 million | 117.0 million |
GTHX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -12.8 million | 3.2 million |
2023-09-30 | -10.6 million | 3.7 million |
2023-06-30 | 14.1 million | 3.8 million |
2023-03-31 | -29.1 million | 3.8 million |
GTHX Net Income
No data available :(
GTHX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 82.2 million | - | 4.3 million |
2023-09-30 | 94.4 million | - | 4.7 million |
2023-06-30 | 104.2 million | 50.9 million | 5.0 million |
2023-03-31 | 116.3 million | 77.5 million | 5.3 million |
GTHX Shares Outstanding
GTHX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 7.4 million | 15.2 million | - |
2023-09-30 | - | 8.8 million | 16.8 million | - |
2023-06-30 | - | 12.0 million | 18.8 million | - |
2023-03-31 | - | 15.5 million | 23.2 million | - |
GTHX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 14.9 million | 1.3 million |
2023-09-30 | 12.3 million | 3.1 million |
2023-06-30 | 42.4 million | 1.4 million |
2023-03-31 | 12.9 million | 1.5 million |
GTHX
Price: $3.99
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -1.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 586179
Ebitda: -15.9 millionMarket Capitalization: 225.0 million